U.S. Patents Assigned to UT Board of Regents
Naming UT Southwestern Investigators as Inventors

This list does not necessarily reflect technologies available for licensing.  If you would like additional information on any of the following patents, please go to our Information Request Page.

U.S. Patent Number: 6,936,723
Patent Title: Synthetic Salicylihalamides, Apicularens and Derivatives Thereof.
Inventors: De Brabander, Jef; Wu, Yusheng.
Issued: 08/30/05.

U.S. Patent Number: 6,936,431
Patent Title: Methods and Compositions for Inhibiting Farnesyl Transferase Enzyme.
Inventors: Brown, Michael S.; Goldstein, Joseph L.; Reiss, Yuval.
Issued: 08/30/05.

U.S. Patent Number: 6,923,965
Patent Title: Modulators of Polysaccharides and Uses Thereof.
Inventors: Takashima, Akira; Mummert, Mark E.; Mohamadzadeh, Mansour.
Issued: 08/02/05.

U.S. Patent Number: 6,924,415
Patent Title: Transgenic Mice Comprising a Constitutively-Activated MEK5 and Exhibiting Cardiac Hypertrophy and Dilated Cardiomyopathy.
Inventors: Olson, Eric N.; Nicol, Rebekka.
Issued: 08/02/05.

U.S. Patent Number: 6,903,135
Patent Title: Methods and Products Relating to 16-Hete Analogs.
Inventors: Falck, John R.; Bednar, Martin M.; Gross, Cordell E.; Balazy, Michael.
Issued: 06/07/05.

U.S. Patent Number: 6,900,018
Patent Title: Method of Screening for a Biological Response Using Linear and Circular Expression Elements.
Inventors: Sykes, Kathryn F.; Johnston, Stephen A.
Issued: 05/31/05.

U.S. Patent Number: 6,893,830
Patent Title: Method of Screening Oxysterol Activation of LXRa.
Inventors: Janowski, Bethany A.; Mangelsdorf, David J.
Issued: 05/17/05.

U.S. Patent Number: 6,887,468
Patent Title: Antibody Kits for Selectively Inhibiting VEGF.
Inventors: Thorpe, Philip E.; Brekken, Rolf A.
Issued: 05/03/05.

U.S. Patent Number: 6,852,969
Patent Title: Inhibitors of Glycosaminoglycans.
Inventors: Takashima, Akira; Mummert, Mark E.
Issued: 02/08/05.

U.S. Patent Number: 6,846,807
Patent Title: Colorectal Neoplasia Prophylaxis.
Inventors: Graff, Jonathan; Wieduwilt, Matthew.
Issued: 01/25/05.

U.S. Patent Number: 6,835,866
Patent Title: Compositions and Methods of Modulating Cholesterol Metabolism.
Inventors: Mangelsdorf, David J.; Repa, Joyce J.; Turley, Stephen D.; Dietschy, John M.
Issued: 12/28/04.

U.S. Patent Number: 6,821,750
Patent Title: ABCG8 Vectors, Host Cells, and Method of Making.
Inventors: Hobbs, Helen H.; Shan, Bei; Barnes, Robert; Tian, Hui.
Issued: 11/23/04.

U.S. Patent Number: 6,821,505
Patent Title: Immunoglobulin-Like Domains with Increased Half Lives.
Inventors: Ward, Elizabeth S.
Issued: 11/23/04.

U.S. Patent Number: 6,819,807
Patent Title: Optical Correlator Using Spatial Light Modulator Illumination.
Inventors: Garner, Harold R.; Gale, Richard O.
Issued: 11/16/04.

U.S. Patent Number: 6,818,213
Patent Title: Cancer Treatment Compositions Comprising Therapeutic Conjugates that Bind to Aminophospholipids.
Inventors: Thorpe, Philip E.; Ran, Sophia; Brekken, Rolf A.
Issued: 11/16/04.

U.S. Patent Number: 6,812,342
Patent Title: Esters of Cyclic ADP Ribose Derivatives.
Inventors: Li, Wen Hong.
Issued: 11/02/04.

U.S. Patent Number: 6,790,648
Patent Title: DNA Fragmentation Factor Involved in Apoptosis.
Inventors: Wang, Xiaodong; Liu, Xuesong.
Issued: 09/14/04.

U.S. Patent Number: 6,790,633
Patent Title: Method of Treatment of a Human with a Farnesyl Transferase Inhibitors.
Inventors: Brown, Michael S.; Goldstein Joseph L.; Reiss,Yuval.
Issued: 09/14/04.